Non-invasive ventilation for general paediatricians
4 affiliations
- 1Pediatric Medicine, Critical Care Division, Sidra Medicine, Doha, Qatar
- 2Department of Clinical Pediatrics, Weill Cornell Medicine-Qatar, Doha, Qatar
- 3Pediatric Intensive Care Unit, Hospital Universitario Central de Asturias, Oviedo, Spain
- 4Pediatric Intensive Care Unit, Hospital Sant Joan de Déu, Barcelona, Spain
Abstract
Over the past two decades, non-invasive ventilation (NIV) has transitioned from being primarily used in specialist intensive care units to becoming a standard intervention in high dependency units, general paediatric units, emergency departments, and increasingly, patients’ homes. Despite this expansion, many general paediatricians still perceive NIV as outside their primary expertise. With this review, we aim to address that gap and equip general paediatricians with the knowledge and confidence to appropriately initiate NIV, monitor its effectiveness, and recognise when escalation of care is required. We narratively reviewed the physiological rationale for non-invasive respiratory support (NRS), including high-flow nasal cannula (HFNC) and the two principal modalities of NIV—continuous positive airway pressure (CPAP) and bilevel positive airway pressure (BiPAP)—and summarised disease-specific evidence from recent literature, including randomised trials, systematic reviews, and international consensus statements. This is a narrative rather than a systematic review: we searched PubMed/MEDLINE and Paediatric Respiratory Reviews for English-language publications from January 2018 to June 2026 using the terms “non-invasive ventilation”, “high-flow nasal cannula”, “CPAP”, “BiPAP”, and “children”, supplemented by references already known to the authors, and selected articles for relevance and recency, prioritising randomised trials, systematic reviews, and consensus statements. HFNC is an oxygenation device rather than a ventilatory device, and its mechanism, clinical applications, and therapeutic goals differ from CPAP and BiPAP. We introduce the Indications, Contraindications, Equipment, Mode and settings, Assessment and monitoring, Next steps (ICEMAN) framework as a practical tool for structured and safe initiation of NIV in routine clinical practice, and apply it across bronchiolitis, acute severe asthma, pneumonia and hypoxaemic respiratory failure, neuromuscular disease, and obstructive sleep apnoea. Conclusion: The essential requirements to initiate NIV outside the PICU are well-trained staff, appropriate monitoring, a reliable oxygen supply, and a clear plan for escalation to a higher level of care. Selection of patients for NIV outside the PICU requires careful attention to indication, contraindications, equipment, monitoring, and escalation pathway by using frameworks like ICEMAN. What is Known:
• HFNC, CPAP, and BiPAP are established, physiologically distinct respiratory therapies now used well beyond the PICU.
What is New:
• The ICEMAN framework, updated with PALICC-2 ARDS criteria, gives non-specialists a structured, teachable approach to safe NIV initiation.
Related
- Nasal intermittent positive pressure ventilation versus nasal continuous positive airway pressure as initial respiratory support during minimally invasive surfactant therapy in preterm infants with respiratory distress syndrome: a retrospective real-world cohort study
- Daily sedation interruption versus no daily sedation interruption for critically ill adults and children requiring invasive mechanical ventilation
- Association between invasive mechanical ventilation and acute kidney injury in critically ill patients: a protocol for a systematic review and meta-analysis of randomised controlled trials.
- Photobiomodulation therapy combined with a static magnetic field in critically ill patients receiving invasive mechanical ventilation: protocol for a multicentre randomised triple-blind placebo-controlled trial.
- A case report-prone position ventilation as an ECMO sparing strategy for re-expansion pulmonary edema following minimally invasive cardiac surgery.
BibTeX
@article{sundaram2026noninvasive,
title = {{Non-invasive ventilation for general paediatricians}},
author = {Manu Sundaram and Alberto Medina and Marti Pons-Òdena},
journal = {European Journal of Pediatrics},
year = {2026},
month = oct,
doi = {10.1007/s00431-026-07489-y},
url = {https://doi.org/10.1007/s00431-026-07489-y},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Non-invasive ventilation for general paediatricians
AU - Manu Sundaram
AU - Alberto Medina
AU - Marti Pons-Òdena
PY - 2026
DA - 2026/10/26
JO - European Journal of Pediatrics
DO - 10.1007/s00431-026-07489-y
UR - https://doi.org/10.1007/s00431-026-07489-y
AB - Over the past two decades, non-invasive ventilation (NIV) has transitioned from being primarily used in specialist intensive care units to becoming a standard intervention in high dependency units, general paediatric units, emergency departments, and increasingly, patients’ homes. Despite this expansion, many general paediatricians still perceive NIV as outside their primary expertise. With this review, we aim to address that gap and equip general paediatricians with the knowledge and confidence to appropriately initiate NIV, monitor its effectiveness, and recognise when escalation of care is required. We narratively reviewed the physiological rationale for non-invasive respiratory support (NRS), including high-flow nasal cannula (HFNC) and the two principal modalities of NIV—continuous positive airway pressure (CPAP) and bilevel positive airway pressure (BiPAP)—and summarised disease-specific evidence from recent literature, including randomised trials, systematic reviews, and international consensus statements. This is a narrative rather than a systematic review: we searched PubMed/MEDLINE and Paediatric Respiratory Reviews for English-language publications from January 2018 to June 2026 using the terms “non-invasive ventilation”, “high-flow nasal cannula”, “CPAP”, “BiPAP”, and “children”, supplemented by references already known to the authors, and selected articles for relevance and recency, prioritising randomised trials, systematic reviews, and consensus statements. HFNC is an oxygenation device rather than a ventilatory device, and its mechanism, clinical applications, and therapeutic goals differ from CPAP and BiPAP. We introduce the Indications, Contraindications, Equipment, Mode and settings, Assessment and monitoring, Next steps (ICEMAN) framework as a practical tool for structured and safe initiation of NIV in routine clinical practice, and apply it across bronchiolitis, acute severe asthma, pneumonia and hypoxaemic respiratory failure, neuromuscular disease, and obstructive sleep apnoea. Conclusion: The essential requirements to initiate NIV outside the PICU are well-trained staff, appropriate monitoring, a reliable oxygen supply, and a clear plan for escalation to a higher level of care. Selection of patients for NIV outside the PICU requires careful attention to indication, contraindications, equipment, monitoring, and escalation pathway by using frameworks like ICEMAN. What is Known: • HFNC, CPAP, and BiPAP are established, physiologically distinct respiratory therapies now used well beyond the PICU. What is New: • The ICEMAN framework, updated with PALICC-2 ARDS criteria, gives non-specialists a structured, teachable approach to safe NIV initiation.
SN - 0340-6199
SN - 1432-1076
ER -